-
動態
9月12日，深圳大學附屬華南醫院泌尿外科學科帶頭人吳鬆教授帶領團隊，與德國夏洛特大學綜合醫院泌尿外科主任、歐洲泌尿外科領域領軍人物Schlommjiaoshou，juxingleyichanggaoshuipingdezhongdexianshangxueshujiaoliu。huiyiyoushenzhendaxuefushuhuananyiyuanminiaowaikezhurenhoutengzhuchi，wusongjiaoshouzhihuanyingci，weishuangfangdeshenruduihualakailexumu。zaisuihoudejieshaohuanjie，tumenjiangboshixiangxihuibaoleshenzhendaxuefushuhuananyiyuanminiaowaikedelinchuangyukeyanchengguo。zuoweiyigechenglijinsanniandenianqingkeshi，gaituanduipingjiekuaisufazhanhezhashichengji，yijingzhanxianchuyuguojijieguideshili。Schlomm教授對這一成就表示高度讚賞，並指出雙方團隊在泌尿係統腫瘤、基因組學研究以及人工智能在醫學中的應用等方麵有著天然的契合點。作為歐洲泌尿外科的權威專家，Schlomm教授以“夏洛特—深圳對話：通過科研與臨床經驗共享推動泌尿外科發展”為(wei)主(zhu)題(ti)，帶(dai)來(lai)了(le)係(xi)統(tong)而(er)深(shen)刻(ke)的(de)分(fen)享(xiang)。在(zai)臨(lin)床(chuang)方(fang)麵(mian)，他(ta)重(zhong)點(dian)介(jie)紹(shao)了(le)自(zi)己(ji)團(tuan)隊(dui)首(shou)創(chuang)的(de)全(quan)功(gong)能(neng)尿(niao)道(dao)括(kuo)約(yue)肌(ji)保(bao)留(liu)前(qian)列(lie)腺(xian)癌(ai)根(gen)治(zhi)術(shu)。這(zhe)一(yi)術(shu)式(shi)的(de)創(chuang)新(xin)突(tu)破(po)了(le)傳(chuan)統(tong)手(shou)術(shu)的(de)局(ju)限(xian)，在(zai)保(bao)證(zheng)腫(zhong)瘤(liu)治(zhi)療(liao)效(xiao)果(guo)的(de)同(tong)時(shi)，大(da)幅(fu)提(ti)升(sheng)了(le)患(huan)者(zhe)術(shu)後(hou)的(de)尿(niao)控(kong)功(gong)能(neng)和(he)生(sheng)活(huo)質(zhi)量(liang)，被(bei)譽(yu)為(wei)改(gai)善(shan)患(huan)者(zhe)生(sheng)存(cun)質(zhi)量(liang)的(de)重(zhong)要(yao)裏(li)程(cheng)碑(bei)。在(zai)科(ke)研(yan)層(ceng)麵(mian)，Schlomm教jiao授shou展zhan示shi了le他ta們men如ru何he利li用yong人ren工gong智zhi能neng與yu基ji因yin數shu據ju相xiang結jie合he，推tui動dong精jing準zhun醫yi療liao的de發fa展zhan。通tong過guo對dui大da規gui模mo真zhen實shi世shi界jie數shu據ju與yu分fen子zi層ceng麵mian數shu據ju的de整zheng合he分fen析xi，他ta們men能neng夠gou開kai發fa出chu動dong態tai預yu測ce算suan法fa，不bu僅jin幫bang助zhu醫yi生sheng更geng好hao地di為wei患huan者zhe製zhi定ding個ge性xing化hua治zhi療liao方fang案an，也ye為wei理li解jie疾ji病bing發fa展zhan和he耐nai藥yao機ji製zhi提ti供gong了le新xin思si路lu。這zhe些xie探tan索suo正zheng在zai逐zhu漸jian改gai變bian泌mi尿niao外wai科ke的de診zhen療liao模mo式shi，讓rang醫yi學xue從cong“經驗驅動”走向“數據驅動”。會(hui)議(yi)氣(qi)氛(fen)熱(re)烈(lie)而(er)真(zhen)誠(cheng)，雙(shuang)方(fang)在(zai)分(fen)享(xiang)經(jing)驗(yan)與(yu)交(jiao)流(liu)思(si)路(lu)中(zhong)找(zhao)到(dao)了(le)諸(zhu)多(duo)共(gong)鳴(ming)。未(wei)來(lai)，中(zhong)德(de)雙(shuang)方(fang)將(jiang)繼(ji)續(xu)攜(xie)手(shou)合(he)作(zuo)，不(bu)僅(jin)在(zai)臨(lin)床(chuang)診(zhen)療(liao)技(ji)術(shu)上(shang)互(hu)學(xue)互(hu)鑒(jian)，更(geng)在(zai)科(ke)研(yan)創(chuang)新(xin)上(shang)深(shen)度(du)融(rong)合(he)，共(gong)同(tong)探(tan)索(suo)泌(mi)尿(niao)外(wai)科(ke)的(de)前(qian)沿(yan)方(fang)向(xiang)。這(zhe)場(chang)跨(kua)越(yue)國(guo)界(jie)的(de)對(dui)話(hua)，不(bu)僅(jin)是(shi)一(yi)場(chang)學(xue)術(shu)盛(sheng)宴(yan)，更(geng)是(shi)合(he)作(zuo)新(xin)征(zheng)程(cheng)的(de)起(qi)點(dian)。
On September 12th, Prof. WU Song, the academic leader of the Department of Urology at South China Hospital of Shenzhen University, together with his team, had a high-level Sino-German online academic exchange with Prof. Schlomm, Director of the Department of Urology at the Charité - Universitätsmedizin Berlin in Germany. The meeting was hosted by HOU Teng, Director of the Department of Urology at South China Hospital of Shenzhen University. Prof. WU Song delivered a welcome speech for the meeting, setting the stage for in-depth dialogue between the two parties. In the subsequent introduction session, Dr. TU Menjiang gave a detailed report on the clinical and research achievements of the Department of Urology at South China Hospital of Shenzhen University. As a young department established only three years ago, the team has demonstrated internationally advanced capabilities through its rapid development and solid accomplishments. Prof. Schlomm expressed high appreciation for these achievements and pointed out that the teams of both parties have natural match in areas such as urological oncology, genomics research, and the application of artificial intelligence in medicine. As a key figure in urology in Europe, Prof. Schlomm delivered a systematic and insightful presentation entitled "Charité-Shenzhen Dialogue: Advancing Urology through Sharing Research and Clinical Experience". In terms of clinical practice, he focused on introducing his team's technique of Full Functional-Length Urethral Sphincter Preservation During Radical Prostatectomy. This innovative surgical method breaks through the limitations of conventional operations, significantly improving patients' postoperative urinary control and quality of life while ensuring effective tumor treatment, and is hailed as an important milestone in enhancing patients' quality of life. Scientifically, Prof. Schlomm demonstrated how they are promoting the development of precision medicine by combining artificial intelligence with genetic data. Through integrated analysis of large-scale real-world data and molecular-level data, they have been able to develop dynamic prediction algorithms that not only help doctors better formulate personalized treatment plans for patients but also provide new insights into understanding disease progression and drug resistance mechanisms. These explorations are gradually changing the diagnosis and treatment model in urology, transforming medicine from "experience-driven" to "data-driven". The meeting was characterized by a warm and sincere atmosphere, with both parties finding much common ground in sharing experiences and exchanging ideas. In the future, the Chinese and German teams both will continue their cooperation, not only learning from each other in clinical diagnosis and treatment but also deeply integrating in scientific research innovation to jointly explore cutting-edge directions in urology. This cross-border dialogue is not only an academic feast but also the starting point of a new journey of cooperation.
